mk1997, I think there's room in the market for both Relenza and LANI. Relenza obviously being the cheaper, multi-dose version and LANI being the single-dose, red Ferrari version.
But I do think they need to be marketed by different companies.
- Forums
- ASX - By Stock
- BTA
- interview with peter cook
interview with peter cook, page-13
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)